Several anti-EGFR aptamers have been developed and demonstrated antitumor effect in various cancers (vulvar carcinoma, lung carcinoma, breast cancer, glioblastoma, and epidermoid carcinoma) [7,8,108,109,110]. This evidence concerns the gene EGFR and squamous cell carcinoma.